Nirmala Bhoo Pathy: I had the opportunity to facilitate an exciting workshop with Novartis through University of Malaya

Nirmala Bhoo Pathy shared a post on LinkedIn:

“Working with pharma?

It’s true that many colleagues, especially in public health, often hesitate to collaborate openly with private industries due to concerns about conflicts of interest and maintaining scientific integrity.

However, the potential for mutual learning and innovation is immense.

I recently had the opportunity to facilitate an exciting workshop with Novartis through University of Malaya, diving deep into the world of clinical research and medical affairs.

This experience reaffirmed that when done right, ethical collaboration between academia and pharma can drive groundbreaking research and lead to innovative solutions.

By declaring conflicts of interest upfront, adhering to strict ethical standards, and maintaining clear, transparent communication, we can ensure these partnerships are both productive and principled.

Thanks to Balraj Sethi for the invitation. Let’s embrace the potential of working together while staying true to our values.”

Source: Nirmala Bhoo Pathy/LinkedIn

Nirmala Bhoo-Pathy is as a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician in Universiti Malaya Medical Centre, Malaysia.

She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014. Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy. Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN).